5 Top Performing European Stocks So Far in 2023
Germany-based VIA optronics AG (NYSE:VIAO) is a display solutions company. VIA optronics AG (NYSE:VIAO) has gained 68% year to date through March 23.
Celyad Oncology Sa (CYAD)
This company is not actively trading or the ticker does belong to another company in our database now.
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Kapitalo Investimentos Jo„O Carlos Pinho And Carlos Woelz | 0 | $0 | 0% | |
| 2. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% | |
| 3. | Fortress Investment Group Michael Novogratz | 0 | $0 | 0% |
Institutional Investors' Holdings
News See All
Celyad Oncology SA (NASDAQ:CYAD) Q4 2022 Earnings Call Transcript
Operator: Greetings. Welcome to the Celyad Oncology Full-Year 2022 Financial Results. At this time, all participants are in a listen-only mode.
Weekly Biotech Report Covering Gilead Sciences, Inc. (GILD) and Celyad SA (ADR) (CYAD)
For the section of our report detailing events in biotech this past couple of weeks, we’ve got two focus companies – one big, one small. They are Gilead Sciences, Inc.
Why Are These Four Stocks Registering Big Gains on Friday?
With the stock market in the green on Friday on the back of a cut in interest rates in China and a boost in the tech sector on the back of earnings (the NASDAQ is up by almost 2%), several companies ...
Hedge Funds Expect Big Things From 1 Of These 2 Sliding Biotechs
Two micro-cap biotech stocks are having a rough start to the week amid generally positive momentum for the market as a whole.
Hedge Fund Resource Center Billionaire Hedge Funds
